- Home
- TNC vs OCS Comparison
TNC vs OCS Comparison
Compare TNC & OCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TNC | OCS |
|---|---|---|
| Founded | 1870 | 2003 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.6B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | TNC | OCS |
|---|---|---|
| Price | $83.21 | $28.57 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 7 |
| Target Price | ★ $102.00 | $39.57 |
| AVG Volume (30 Days) | 99.1K | ★ 336.1K |
| Earning Date | 02-20-2026 | 03-10-2026 |
| Dividend Yield | ★ 1.49% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.91 | N/A |
| Revenue | ★ $1,240,800,000.00 | $991,999.00 |
| Revenue This Year | N/A | $14.53 |
| Revenue Next Year | $5.63 | $691.13 |
| P/E Ratio | $28.54 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $67.32 | $14.00 |
| 52 Week High | $90.44 | $29.36 |
Technical Indicators
Market Signals| Indicator | TNC | OCS |
|---|---|---|
| Relative Strength Index (RSI) | 61.75 | 66.72 |
| Support Level | $80.97 | $27.30 |
| Resistance Level | $83.24 | $29.10 |
| Average True Range (ATR) | 1.66 | 1.24 |
| MACD | 0.25 | -0.14 |
| Stochastic Oscillator | 79.22 | 81.75 |
Price Performance
Historical ComparisonAbout TNC Tennant Company
Tennant Co is a manufacturer of floor cleaning equipment, wood flooring, and wood products. It operates in four geographic business units including North America; Latin America; Europe, Middle East, Africa; and Asia Pacific. The company offers products and solutions consisting of mechanized cleaning equipment, detergent-free, and other sustainable cleaning technologies, aftermarket parts and consumables, equipment maintenance and repair service, specialty surface coatings, and business solutions such as financing, rental and leasing programs, and machine-to-machine asset management solutions.
About OCS Oculis Holding AG Ordinary shares
Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.